trending Market Intelligence /marketintelligence/en/news-insights/trending/k7zfhaTbGCQx5PVmUsmdLg2 content esgSubNav
In This List

Elanco receives 2nd information request from US FTC over $7.6B Bayer deal

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Elanco receives 2nd information request from US FTC over $7.6B Bayer deal

Elanco Animal Health Inc. received a second information request from the U.S. Federal Trade Commission regarding its $7.6 billion acquisition of Bayer AG's animal health business.

Greenfield, Ind.-based Elanco said the request was part of the standard regulatory review process under the Hart-Scott-Rodino Act. The request essentially extends the waiting period imposed under the antitrust act for 30 days after the companies involved have provided the information sought.

The transaction, which is subject to regulatory approval and closing conditions, is still expected to close in mid-2020, according to Elanco.

Elanco has previously said the deal will double its companion animal business, advance the company's intentional portfolio mix transformation and create a balance between its food animal and companion animal segments.